Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman

Journal of Infectious Diseases

Volumn 175, Issue 2 SUPPL., 1997, Pages

  Sutter, Roland W ^a   Suleiman, Ali Jaffer M ^b   Malankar, Pradeep G ^b   Mehta, Firdosi R ^b   Medany, Mahmud A ^b   Arif, Mohammed Amir M ^b   Linkins, Robert W ^b   Pallansch, Mark A ^b   El Bualy, Mussalam S ^b   Robertson, Susan E ^b  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MAGNESIUM CHLORIDE; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; PLACEBO; POLIOMYELITIS VACCINE;

ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; FOLLOW UP; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MUCOSAL IMMUNITY; NEWBORN; OMAN; ORAL DRUG ADMINISTRATION; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROPREVALENCE; VACCINATION; VIRUS EXCRETION; WORLD HEALTH ORGANIZATION;

EID: 8044248408     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.supplement_1.s235     Document Type: Article

References (7)

1. Sutter RW, Patriarca PA, Brogan S, et al. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 1991;338:715-20.
2. Robertson SE, Suleiman AJM, Mehta FR, Al-Dahry SHS, El-Bualy MS. Poliomyelitis in Oman: acute flaccid paralysis surveillance leading to early detection and rapid response to a type 3 outbreak. Bull World Health Organ 1994;72:901-14.
3. Sutter RW, Patriarca PA, Suleiman AJM, et al. Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol 1993;22:936-44.
4. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries. Rev Infect Dis 1991;13:926-39.
5. Patriarca PA, Laender F, Palmeira G, et al. Randomised trial of alternative formulations of oral poliovaccine in Brazil. Lancet 1988;1:429-33.
6. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and The Gambia. J Infect Dis 1995;171:1097-106.
7. Patriarca PA, Linkins RW, Sutter RW, Orenstein WA. Optimal schedule for the administration of oral poliovirus vaccine. In: Kurstak E, ed. Measles and poliomyelitis - vaccines and immunization. New York: Springer, 1993:303-13.